Loading...
Derniers manuscrits de l'équipe
-
Delphine Bredel, Edi Tihic, Séverine Mouraud, François-Xavier Danlos, Sandrine Susini, et al.. Immune checkpoints are predominantly co-expressed by clonally expanded CD4+FoxP3+ intratumoral T-cells in primary human cancers. Journal of experimental & clinical cancer research, 2023, 42, ⟨10.1186/s13046-023-02897-6⟩. ⟨hal-04431918⟩
-
Michele Lodato, Valérie Plaisance, Valérie Pawlowski, Maxime Kwapich, Alexandre Barras, et al.. Venom Peptides, Polyphenols and Alkaloids: Are They the Next Antidiabetics That Will Preserve β-Cell Mass and Function in Type 2 Diabetes?. Cells, 2023, 12 (6), pp.940. ⟨10.3390/cells12060940⟩. ⟨hal-04062633⟩
-
Paolo Antonio Ascierto, Evan Lipson, Reinhard Dummer, James Larkin, Georgina Long, et al.. Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy: Results From the Phase I/IIa RELATIVITY-020 Trial. Journal of Clinical Oncology, 2023, Online ahead of print. ⟨10.1200/JCO.22.02072⟩. ⟨inserm-03996644⟩
Chiffres clés
35
Publications avec texte intégral